| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.3 | 0.09 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |